Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors

Anticancer Research

Volumn 34, Issue 11, 2014, Pages 6417-6422

  Lachaier, Emma ^a,b   Louandre, Christophe ^a,b   Godin, Corinne ^a,b   Saidak, Zuzana ^a,b   Baert, Maxime ^a   Diouf, Momar ^a,b   Chauffert, Bruno ^b   Galmiche, Antoine ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Erastin; Ferroptosis; Sorafenib

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CASPASE 3; CASPASE INHIBITOR; DEFEROXAMINE; DOXORUBICIN; ERASTIN; ERLOTINIB; GEFITINIB; IMATINIB; LACTATE DEHYDROGENASE; MASITINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOTRANSFERASE INHIBITOR; PONATINIB; RAPAMYCIN; SELUMETINIB; SORAFENIB; TIVANTINIB; UNCLASSIFIED DRUG; VEMURAFENIB; CARBANILAMIDE DERIVATIVE; NICOTINAMIDE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL MEMBRANE PERMEABILITY; CHEMOLUMINESCENCE; DRUG EFFICACY; FERROPTOSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY CANCER; LIVER CELL CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; SOLID TUMOR; ANALOGS AND DERIVATIVES; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; NECROSIS; NEOPLASMS; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; HUMANS; L-LACTATE DEHYDROGENASE; NECROSIS; NEOPLASMS; NIACINAMIDE; PHENYLUREA COMPOUNDS; PIPERAZINES; PROTEIN KINASE INHIBITORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84916241447     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Galluzzi L, Vitale I, Vacchelli E and Kroemer G: Cell death signaling and anticancer therapy. Front Oncol 1: 5, 2011.
2. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 15: 135-147, 2014.
3. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd and Stockwell BR: Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149: 1060-1072, 2012.
4. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S and Stockwell BR: RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447: 864-868, 2007.
5. Yang WS, Sriramaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL and Stockwell BR: Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell 156: 317-331, 2014.
6. Dolma S, Lessnick SL, Hahn WC and Stockwell BR: Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3: 285-296, 2003.
7. Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazière JC, Chauffert B and Galmiche A: Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer 133: 1732-1742, 2013.
8. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR and Futreal PA: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945-D950, 2011.
9. Galmiche A, Ezzoukhry Z, Franc¸ois C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Mazière JC and Chatelain D: BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma. Mol Cancer Res 8: 1116-1125, 2010.
10. Stratton MR, Campbell PJ and Futreal PA: The cancer genome. Nature 458: 719-724, 2009.
11. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MD, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ and Ding L: Mutational landscape and significance across 12 major cancer types. Nature 502: 333-339, 2013.
12. Galmiche A, Chauffert B and Barbare JC: New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma. Cancer Lett 346: 159-162, 2014.
13. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK and Zarrinkar PP: Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 29: 1046-1051, 2011.
14. Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS and Stockwell BR: Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife e02523, 2014.
15. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR and Chandel NS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 107: 8788-8793, 2010.
16. Block K and Gorin Y: Aiding and abetting roles of NOX oxidases in cellular transformation. Nat Rev Cancer 12: 627-637, 2012.
17. Go YM and Jones DP: The redox proteome. J Biol Chem 288: 26512-26520, 2013.
18. Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C, Lu W, Burger JA, Croce CM, Plunkett W, Keating MJ and Huang P: Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 14: 276-286, 2012.
19. Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-91, 2009.
20. Benjamin DI, Cravatt BF and Nomura DK: Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metab 16: 565-577, 2012.
21. Xia X, Owen MS, Lee RE and Gaudet S: Cell-to-cell variability in cell death: can systems biology help us make sense of it all? Cell Death Dis 5: e1261, 2014.